Bundamedik Tbk PT
IDX:BMHS
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
240
378
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Bundamedik Tbk PT
Wall Street
Price Targets
BMHS Price Targets Summary
Bundamedik Tbk PT
According to Wall Street analysts, the average 1-year price target for
BMHS
is 295.8 IDR
with a low forecast of 292.9 IDR and a high forecast of 304.5 IDR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BMHS's stock price target?
Price Target
295.8
IDR
According to Wall Street analysts, the average 1-year price target for
BMHS
is 295.8 IDR
with a low forecast of 292.9 IDR and a high forecast of 304.5 IDR.
What is Bundamedik Tbk PT's Revenue forecast?
Projected CAGR
13%
For the last 4 years the
compound annual growth rate for
Bundamedik Tbk PT's revenue is
11%.
The projected
CAGR
for the next 3 years is
13%.
What is Bundamedik Tbk PT's Operating Income forecast?
Projected CAGR
32%
For the last 4 years the
compound annual growth rate for
Bundamedik Tbk PT's operating income is
-3%.
The projected
CAGR
for the next 3 years is
32%.
What is Bundamedik Tbk PT's Net Income forecast?
Projected CAGR
118%
For the last 4 years the
compound annual growth rate for
Bundamedik Tbk PT's net income is
-22%.
The projected
CAGR
for the next 3 years is
118%.
You don't have any saved screeners yet
